First treatments with Valvosoft® now performed in routine clinical practice in Germany 🚀
June 11, 2026
Proud to see the first treatments with Cardiawave technology now performed in routine clinical practice in Germany 🇩🇪 !
Click here to read Prof. Jury Schewels’ Linkedin post:
https://www.linkedin.com/posts/jury-schewel-pd-dr-med-817534153_aortenklappenstenose-ultraschallwellen-aortenklappe-activity-7468708705614663680-IZ3f?utm_source=share&utm_medium=member_desktop&rcm=ACoAABAOtEgBiS-TfTA24iH9k4ZIlQYsPVwEWhg
Alongside Hôpital Européen Georges Pompidou in Paris and CHU de Rouen, these teams are among the first worldwide to bring fully non-invasive ultrasound therapy into everyday care.
No catheter. No surgery. No general anesthesia.
A new way to treat aortic stenosis. 🎯
Kudos to PD Dr. @Jury Schewel and the entire heart team for this milestone, and thanks to the patients for their trust 🙏
We deeply value the feedback from clinicians as they bring this innovation into real-world practice.
Exciting to see a scientific vision becoming reality.
@markienkrankenhaus @CHU de Rouen #MedTech #Cardiology #Innovation #StructuralHeart #AorticStenosis #Valvosoft #medtech #focusedultrasound #NIUT #TAVI #TAVR #AorticValve #lifetimemanagementofas #heartvalves #CEMarking
@AP‑HP, Assistance Publique – Hôpitaux de Paris #HEGP, @Physics for Medicine Paris, #InstitutLangevin, @CNRS, @ESPCI Paris – PSL, @Inserm @RHU_STOP_AS #FrenchCare #Health20 @france-biotech @medicen-paris-region @bpi-france @medtechinfrance @focusedultrasoundfoundation @eic-scalingclub @snitem
